参考文献/References:
[1]李汀,杨利萍,王毅,等. 西安地区胃癌危险因素病例对照研究[J]. 陕西医学杂志,2014,43(3):358361.
[2]张霞,李学锋. 六种常用肿瘤标志物对肺癌的疗效评估和预后[J]. 医学综述,2015,21(23):42884291.
[3]杨含,罗素霞. 六种肿瘤标志物在肺癌诊断中的价值及其临床应用[J]. 现代肿瘤医学,2016,24(4):577581.
[4]魏素姣. 免疫组化标志物在胃癌组织中的表达及意义[J]. 首都食品与医药, 2017, 24(20):4647.
[5]董亮, 钱震, 施蓉蓉,等. 结直肠腺癌组织中p53、HER2和Ki67的表达及其临床病理意义[J]. 诊断病理学杂志, 2015, 22(1):1922.
[6]张洪兰, 张昶, 陈昊. 全自动与手工免疫组化法在检测5种恶性肿瘤Her2表达中的应用[J]. 诊断病理学杂志, 2016, 23(10):796797.
[7]Shim JH, Yoon JH, Choi SS, et al. The effect of Helicobacter pylori, CagA on the HER2,copy number and expression in gastric cancer[J]. Gene, 2014, 546(2):288296.
[8]丁如, 朱昭环. 乳腺浸润性导管癌X线表现与ER、PR、Her2、Ki67、P53表达的相关性研究[J]. 临床和实验医学杂志, 2016, 15(14):13901394.
[9]Yoon HH, Sukov WR, Qian S, et al. HER‐2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma[J]. Cancer, 2014, 120(3):415–424.〖ZK)〗
[10]李惠, 孙怡, 王双双,等. 人表皮生长因子受体2在胃癌活检标本和手术标本中表达及临床意义[J]. 中华实用诊断与治疗杂志, 2016, 30(2):153156.
[11]宋霞,陈涛,王一萍,等. TSGF、AFP、CEA、CA199、CA50联合检测对消化道恶性肿瘤早期诊断价值[J]. 国际检验医学杂志,2015,36(1):118120.
[12]吴永春. 肿瘤标志物对女性生殖道癌及乳腺癌联合筛查的临床价值[J]. 检验医学,2018,33(6):512515.
[13]Pan YQ, Ruan YY, Peng JB, et al. Diagnostic significance of soluble human leukocyte antigenG for gastric cancer[J]. Human Immunology, 2016, 77(4):317324.
[14]潘丽兰. 血清CEA、CA199、CA125、CA153、AFP联合检测对胃癌的诊断价值[J]. 中国实验诊断学, 2013, 17(12):21922195.
[15]Fan B, Xiong B. Investigation of serum tumor markers in the diagnosis of gastric cancer.[J]. Hepatogastroenterology, 2016, 58(105):239245.
[16]王延峰,米志宽,张华华,等.血清蛋白组与消化道恶性肿瘤研究进展[J].陕西医学杂志,2017,46(11):16191620.
相似文献/References:
[1]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(1):435.
[2]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(1):456.
[3]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[4]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(1):679.
[5]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(1):958.
[6]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(1):1010.
[7]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(1):1115.
[8]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[9]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(1):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
[10]张 铭,张新望,艾 静,等.胃癌患者血浆微小RNA-100表达水平及其临床意义*[J].陕西医学杂志,2020,49(7):893.[doi:DOI:10.3969/j.issn.10007377.2020.07.034]
ZHANG Ming,ZHANG Xinwang,AI Jing,et al.Study on expression level of microRNA-100 in plasma of patients with gastric cancer[J].,2020,49(1):893.[doi:DOI:10.3969/j.issn.10007377.2020.07.034]